awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51166031-E964FFB1-E30D-40F9-BEB7-D929EE966223
Q51166031-E964FFB1-E30D-40F9-BEB7-D929EE966223
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51166031-E964FFB1-E30D-40F9-BEB7-D929EE966223
Optimum Dose of Once-Daily Oxybutynin Patch in Japanese Patients with Overactive Bladder: A Randomized Double-Blind Trial Versus Placebo.
P2860
Q51166031-E964FFB1-E30D-40F9-BEB7-D929EE966223
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51166031-E964FFB1-E30D-40F9-BEB7-D929EE966223
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c7ebddf671bda6122a36a2fe6a08453cdb8ee9f
P2860
A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder.